Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high vascular risk
Objective: ACE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are widely prescribed in patients with high cardiovascular (CV) risk. However, whether both classes have equivalent effectiveness to prevent CV events remains unclear. The aim of this study was to compare the incidence of maj...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Journal Article |
| Published: |
BMJ Publishing Group
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/56795 |